CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-09 | Pascoe Richard W Chief Executive Officer | Purchase | +10,000 | $4.20 | $42K | 29,973 |
| 2023-01-13 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +610 | $5.82 | $4K | 9,252 |
| 2023-01-13 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +25 | $5.59 | $140 | 9,277 |
| 2023-01-13 | Pascoe Richard W Chief Executive Officer | Purchase | +9,500 | $5.44 | $52K | 19,973 |
| 2023-01-09 | Clifton R. LaDuane CFO, Secretary & Treasurer | Grant or award · Stock Option (right to buy) | +459,726 | 459,726 | ||
| 2023-01-09 | Mickle Christal M M Chief Product Dev. Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 |
Page 9 of 9 · 166 trades